HRMY Q1 2020 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M

Gross Profit

$16M82.5% margin

Operating Income

-$10M-48.4% margin

Net Income

-$39M-194.7% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

+230.9%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$368,000

Balance Sheet

Total Assets

$163M

Total Liabilities

$209M

Stockholders' Equity

-$46M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$0	—
Gross Profit	$16M	$0	—
Operating Income	-$10M	-$63M	+84.8%
Net Income	-$39M	-$63M	+38.7%